Global CAR-T Cell Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global CAR-T Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global CAR-T Cell Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global CAR-T Cell Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global CAR-T Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global CAR-T Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global CAR-T Cell Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR-T Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR-T Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb, Gilead Sciences, Novartis, Autolus and Janssen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
CAR-T Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe CAR-T Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CAR-T Cell Therapy, with price, sales, revenue and global market share of CAR-T Cell Therapy from 2018 to 2023.
Chapter 3, the CAR-T Cell Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CAR-T Cell Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and CAR-T Cell Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of CAR-T Cell Therapy.
Chapter 14 and 15, to describe CAR-T Cell Therapy sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global CAR-T Cell Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global CAR-T Cell Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global CAR-T Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global CAR-T Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global CAR-T Cell Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR-T Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR-T Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb, Gilead Sciences, Novartis, Autolus and Janssen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
CAR-T Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- CD19
- BCMA
- CD19/CD22
- Other
- Non-hodgkin Lymphoma
- Multiple Myeloma
- Acute Lymphoblastic Leukemia
- Other
- Bristol Myers Squibb
- Gilead Sciences
- Novartis
- Autolus
- Janssen
- JW Therapeutics
- Beijing Immunochina Medical Science & Technology
- Bioray Laboratories
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe CAR-T Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CAR-T Cell Therapy, with price, sales, revenue and global market share of CAR-T Cell Therapy from 2018 to 2023.
Chapter 3, the CAR-T Cell Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CAR-T Cell Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and CAR-T Cell Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of CAR-T Cell Therapy.
Chapter 14 and 15, to describe CAR-T Cell Therapy sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of CAR-T Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global CAR-T Cell Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 CD19
1.3.3 BCMA
1.3.4 CD19/CD22
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global CAR-T Cell Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Non-hodgkin Lymphoma
1.4.3 Multiple Myeloma
1.4.4 Acute Lymphoblastic Leukemia
1.4.5 Other
1.5 Global CAR-T Cell Therapy Market Size & Forecast
1.5.1 Global CAR-T Cell Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global CAR-T Cell Therapy Sales Quantity (2018-2029)
1.5.3 Global CAR-T Cell Therapy Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Bristol Myers Squibb
2.1.1 Bristol Myers Squibb Details
2.1.2 Bristol Myers Squibb Major Business
2.1.3 Bristol Myers Squibb CAR-T Cell Therapy Product and Services
2.1.4 Bristol Myers Squibb CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bristol Myers Squibb Recent Developments/Updates
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR-T Cell Therapy Product and Services
2.2.4 Gilead Sciences CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis CAR-T Cell Therapy Product and Services
2.3.4 Novartis CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments/Updates
2.4 Autolus
2.4.1 Autolus Details
2.4.2 Autolus Major Business
2.4.3 Autolus CAR-T Cell Therapy Product and Services
2.4.4 Autolus CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Autolus Recent Developments/Updates
2.5 Janssen
2.5.1 Janssen Details
2.5.2 Janssen Major Business
2.5.3 Janssen CAR-T Cell Therapy Product and Services
2.5.4 Janssen CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Janssen Recent Developments/Updates
2.6 JW Therapeutics
2.6.1 JW Therapeutics Details
2.6.2 JW Therapeutics Major Business
2.6.3 JW Therapeutics CAR-T Cell Therapy Product and Services
2.6.4 JW Therapeutics CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 JW Therapeutics Recent Developments/Updates
2.7 Beijing Immunochina Medical Science & Technology
2.7.1 Beijing Immunochina Medical Science & Technology Details
2.7.2 Beijing Immunochina Medical Science & Technology Major Business
2.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product and Services
2.7.4 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Beijing Immunochina Medical Science & Technology Recent Developments/Updates
2.8 Bioray Laboratories
2.8.1 Bioray Laboratories Details
2.8.2 Bioray Laboratories Major Business
2.8.3 Bioray Laboratories CAR-T Cell Therapy Product and Services
2.8.4 Bioray Laboratories CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bioray Laboratories Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CAR-T CELL THERAPY BY MANUFACTURER
3.1 Global CAR-T Cell Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global CAR-T Cell Therapy Revenue by Manufacturer (2018-2023)
3.3 Global CAR-T Cell Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of CAR-T Cell Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 CAR-T Cell Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 CAR-T Cell Therapy Manufacturer Market Share in 2022
3.5 CAR-T Cell Therapy Market: Overall Company Footprint Analysis
3.5.1 CAR-T Cell Therapy Market: Region Footprint
3.5.2 CAR-T Cell Therapy Market: Company Product Type Footprint
3.5.3 CAR-T Cell Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global CAR-T Cell Therapy Market Size by Region
4.1.1 Global CAR-T Cell Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global CAR-T Cell Therapy Consumption Value by Region (2018-2029)
4.1.3 Global CAR-T Cell Therapy Average Price by Region (2018-2029)
4.2 North America CAR-T Cell Therapy Consumption Value (2018-2029)
4.3 Europe CAR-T Cell Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific CAR-T Cell Therapy Consumption Value (2018-2029)
4.5 South America CAR-T Cell Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa CAR-T Cell Therapy Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
5.2 Global CAR-T Cell Therapy Consumption Value by Type (2018-2029)
5.3 Global CAR-T Cell Therapy Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
6.2 Global CAR-T Cell Therapy Consumption Value by Application (2018-2029)
6.3 Global CAR-T Cell Therapy Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
7.2 North America CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
7.3 North America CAR-T Cell Therapy Market Size by Country
7.3.1 North America CAR-T Cell Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America CAR-T Cell Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
8.2 Europe CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
8.3 Europe CAR-T Cell Therapy Market Size by Country
8.3.1 Europe CAR-T Cell Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe CAR-T Cell Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific CAR-T Cell Therapy Market Size by Region
9.3.1 Asia-Pacific CAR-T Cell Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific CAR-T Cell Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
10.2 South America CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
10.3 South America CAR-T Cell Therapy Market Size by Country
10.3.1 South America CAR-T Cell Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America CAR-T Cell Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa CAR-T Cell Therapy Market Size by Country
11.3.1 Middle East & Africa CAR-T Cell Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa CAR-T Cell Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 CAR-T Cell Therapy Market Drivers
12.2 CAR-T Cell Therapy Market Restraints
12.3 CAR-T Cell Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of CAR-T Cell Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of CAR-T Cell Therapy
13.3 CAR-T Cell Therapy Production Process
13.4 CAR-T Cell Therapy Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 CAR-T Cell Therapy Typical Distributors
14.3 CAR-T Cell Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of CAR-T Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global CAR-T Cell Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 CD19
1.3.3 BCMA
1.3.4 CD19/CD22
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global CAR-T Cell Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Non-hodgkin Lymphoma
1.4.3 Multiple Myeloma
1.4.4 Acute Lymphoblastic Leukemia
1.4.5 Other
1.5 Global CAR-T Cell Therapy Market Size & Forecast
1.5.1 Global CAR-T Cell Therapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global CAR-T Cell Therapy Sales Quantity (2018-2029)
1.5.3 Global CAR-T Cell Therapy Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Bristol Myers Squibb
2.1.1 Bristol Myers Squibb Details
2.1.2 Bristol Myers Squibb Major Business
2.1.3 Bristol Myers Squibb CAR-T Cell Therapy Product and Services
2.1.4 Bristol Myers Squibb CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bristol Myers Squibb Recent Developments/Updates
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR-T Cell Therapy Product and Services
2.2.4 Gilead Sciences CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis CAR-T Cell Therapy Product and Services
2.3.4 Novartis CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments/Updates
2.4 Autolus
2.4.1 Autolus Details
2.4.2 Autolus Major Business
2.4.3 Autolus CAR-T Cell Therapy Product and Services
2.4.4 Autolus CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Autolus Recent Developments/Updates
2.5 Janssen
2.5.1 Janssen Details
2.5.2 Janssen Major Business
2.5.3 Janssen CAR-T Cell Therapy Product and Services
2.5.4 Janssen CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Janssen Recent Developments/Updates
2.6 JW Therapeutics
2.6.1 JW Therapeutics Details
2.6.2 JW Therapeutics Major Business
2.6.3 JW Therapeutics CAR-T Cell Therapy Product and Services
2.6.4 JW Therapeutics CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 JW Therapeutics Recent Developments/Updates
2.7 Beijing Immunochina Medical Science & Technology
2.7.1 Beijing Immunochina Medical Science & Technology Details
2.7.2 Beijing Immunochina Medical Science & Technology Major Business
2.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product and Services
2.7.4 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Beijing Immunochina Medical Science & Technology Recent Developments/Updates
2.8 Bioray Laboratories
2.8.1 Bioray Laboratories Details
2.8.2 Bioray Laboratories Major Business
2.8.3 Bioray Laboratories CAR-T Cell Therapy Product and Services
2.8.4 Bioray Laboratories CAR-T Cell Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bioray Laboratories Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CAR-T CELL THERAPY BY MANUFACTURER
3.1 Global CAR-T Cell Therapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global CAR-T Cell Therapy Revenue by Manufacturer (2018-2023)
3.3 Global CAR-T Cell Therapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of CAR-T Cell Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 CAR-T Cell Therapy Manufacturer Market Share in 2022
3.4.2 Top 6 CAR-T Cell Therapy Manufacturer Market Share in 2022
3.5 CAR-T Cell Therapy Market: Overall Company Footprint Analysis
3.5.1 CAR-T Cell Therapy Market: Region Footprint
3.5.2 CAR-T Cell Therapy Market: Company Product Type Footprint
3.5.3 CAR-T Cell Therapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global CAR-T Cell Therapy Market Size by Region
4.1.1 Global CAR-T Cell Therapy Sales Quantity by Region (2018-2029)
4.1.2 Global CAR-T Cell Therapy Consumption Value by Region (2018-2029)
4.1.3 Global CAR-T Cell Therapy Average Price by Region (2018-2029)
4.2 North America CAR-T Cell Therapy Consumption Value (2018-2029)
4.3 Europe CAR-T Cell Therapy Consumption Value (2018-2029)
4.4 Asia-Pacific CAR-T Cell Therapy Consumption Value (2018-2029)
4.5 South America CAR-T Cell Therapy Consumption Value (2018-2029)
4.6 Middle East and Africa CAR-T Cell Therapy Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
5.2 Global CAR-T Cell Therapy Consumption Value by Type (2018-2029)
5.3 Global CAR-T Cell Therapy Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
6.2 Global CAR-T Cell Therapy Consumption Value by Application (2018-2029)
6.3 Global CAR-T Cell Therapy Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
7.2 North America CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
7.3 North America CAR-T Cell Therapy Market Size by Country
7.3.1 North America CAR-T Cell Therapy Sales Quantity by Country (2018-2029)
7.3.2 North America CAR-T Cell Therapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
8.2 Europe CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
8.3 Europe CAR-T Cell Therapy Market Size by Country
8.3.1 Europe CAR-T Cell Therapy Sales Quantity by Country (2018-2029)
8.3.2 Europe CAR-T Cell Therapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific CAR-T Cell Therapy Market Size by Region
9.3.1 Asia-Pacific CAR-T Cell Therapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific CAR-T Cell Therapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
10.2 South America CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
10.3 South America CAR-T Cell Therapy Market Size by Country
10.3.1 South America CAR-T Cell Therapy Sales Quantity by Country (2018-2029)
10.3.2 South America CAR-T Cell Therapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa CAR-T Cell Therapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa CAR-T Cell Therapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa CAR-T Cell Therapy Market Size by Country
11.3.1 Middle East & Africa CAR-T Cell Therapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa CAR-T Cell Therapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 CAR-T Cell Therapy Market Drivers
12.2 CAR-T Cell Therapy Market Restraints
12.3 CAR-T Cell Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of CAR-T Cell Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of CAR-T Cell Therapy
13.3 CAR-T Cell Therapy Production Process
13.4 CAR-T Cell Therapy Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 CAR-T Cell Therapy Typical Distributors
14.3 CAR-T Cell Therapy Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global CAR-T Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global CAR-T Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol Myers Squibb Major Business
Table 5. Bristol Myers Squibb CAR-T Cell Therapy Product and Services
Table 6. Bristol Myers Squibb CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bristol Myers Squibb Recent Developments/Updates
Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences Major Business
Table 10. Gilead Sciences CAR-T Cell Therapy Product and Services
Table 11. Gilead Sciences CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gilead Sciences Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis CAR-T Cell Therapy Product and Services
Table 16. Novartis CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Recent Developments/Updates
Table 18. Autolus Basic Information, Manufacturing Base and Competitors
Table 19. Autolus Major Business
Table 20. Autolus CAR-T Cell Therapy Product and Services
Table 21. Autolus CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Autolus Recent Developments/Updates
Table 23. Janssen Basic Information, Manufacturing Base and Competitors
Table 24. Janssen Major Business
Table 25. Janssen CAR-T Cell Therapy Product and Services
Table 26. Janssen CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Janssen Recent Developments/Updates
Table 28. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. JW Therapeutics Major Business
Table 30. JW Therapeutics CAR-T Cell Therapy Product and Services
Table 31. JW Therapeutics CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. JW Therapeutics Recent Developments/Updates
Table 33. Beijing Immunochina Medical Science & Technology Basic Information, Manufacturing Base and Competitors
Table 34. Beijing Immunochina Medical Science & Technology Major Business
Table 35. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product and Services
Table 36. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Beijing Immunochina Medical Science & Technology Recent Developments/Updates
Table 38. Bioray Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Bioray Laboratories Major Business
Table 40. Bioray Laboratories CAR-T Cell Therapy Product and Services
Table 41. Bioray Laboratories CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bioray Laboratories Recent Developments/Updates
Table 43. Global CAR-T Cell Therapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global CAR-T Cell Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global CAR-T Cell Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in CAR-T Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and CAR-T Cell Therapy Production Site of Key Manufacturer
Table 48. CAR-T Cell Therapy Market: Company Product Type Footprint
Table 49. CAR-T Cell Therapy Market: Company Product Application Footprint
Table 50. CAR-T Cell Therapy New Market Entrants and Barriers to Market Entry
Table 51. CAR-T Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global CAR-T Cell Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global CAR-T Cell Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global CAR-T Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global CAR-T Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global CAR-T Cell Therapy Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global CAR-T Cell Therapy Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global CAR-T Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global CAR-T Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global CAR-T Cell Therapy Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global CAR-T Cell Therapy Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global CAR-T Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global CAR-T Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global CAR-T Cell Therapy Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global CAR-T Cell Therapy Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America CAR-T Cell Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America CAR-T Cell Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America CAR-T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America CAR-T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe CAR-T Cell Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe CAR-T Cell Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe CAR-T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe CAR-T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific CAR-T Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific CAR-T Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America CAR-T Cell Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America CAR-T Cell Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America CAR-T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America CAR-T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa CAR-T Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa CAR-T Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 110. CAR-T Cell Therapy Raw Material
Table 111. Key Manufacturers of CAR-T Cell Therapy Raw Materials
Table 112. CAR-T Cell Therapy Typical Distributors
Table 113. CAR-T Cell Therapy Typical Customers
Table 1. Global CAR-T Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global CAR-T Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol Myers Squibb Major Business
Table 5. Bristol Myers Squibb CAR-T Cell Therapy Product and Services
Table 6. Bristol Myers Squibb CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bristol Myers Squibb Recent Developments/Updates
Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences Major Business
Table 10. Gilead Sciences CAR-T Cell Therapy Product and Services
Table 11. Gilead Sciences CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gilead Sciences Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis CAR-T Cell Therapy Product and Services
Table 16. Novartis CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Recent Developments/Updates
Table 18. Autolus Basic Information, Manufacturing Base and Competitors
Table 19. Autolus Major Business
Table 20. Autolus CAR-T Cell Therapy Product and Services
Table 21. Autolus CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Autolus Recent Developments/Updates
Table 23. Janssen Basic Information, Manufacturing Base and Competitors
Table 24. Janssen Major Business
Table 25. Janssen CAR-T Cell Therapy Product and Services
Table 26. Janssen CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Janssen Recent Developments/Updates
Table 28. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. JW Therapeutics Major Business
Table 30. JW Therapeutics CAR-T Cell Therapy Product and Services
Table 31. JW Therapeutics CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. JW Therapeutics Recent Developments/Updates
Table 33. Beijing Immunochina Medical Science & Technology Basic Information, Manufacturing Base and Competitors
Table 34. Beijing Immunochina Medical Science & Technology Major Business
Table 35. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product and Services
Table 36. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Beijing Immunochina Medical Science & Technology Recent Developments/Updates
Table 38. Bioray Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Bioray Laboratories Major Business
Table 40. Bioray Laboratories CAR-T Cell Therapy Product and Services
Table 41. Bioray Laboratories CAR-T Cell Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bioray Laboratories Recent Developments/Updates
Table 43. Global CAR-T Cell Therapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global CAR-T Cell Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global CAR-T Cell Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in CAR-T Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and CAR-T Cell Therapy Production Site of Key Manufacturer
Table 48. CAR-T Cell Therapy Market: Company Product Type Footprint
Table 49. CAR-T Cell Therapy Market: Company Product Application Footprint
Table 50. CAR-T Cell Therapy New Market Entrants and Barriers to Market Entry
Table 51. CAR-T Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global CAR-T Cell Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global CAR-T Cell Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global CAR-T Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global CAR-T Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global CAR-T Cell Therapy Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global CAR-T Cell Therapy Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global CAR-T Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global CAR-T Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global CAR-T Cell Therapy Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global CAR-T Cell Therapy Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global CAR-T Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global CAR-T Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global CAR-T Cell Therapy Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global CAR-T Cell Therapy Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America CAR-T Cell Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America CAR-T Cell Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America CAR-T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America CAR-T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe CAR-T Cell Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe CAR-T Cell Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe CAR-T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe CAR-T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific CAR-T Cell Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific CAR-T Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific CAR-T Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America CAR-T Cell Therapy Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America CAR-T Cell Therapy Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America CAR-T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America CAR-T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa CAR-T Cell Therapy Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa CAR-T Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa CAR-T Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 110. CAR-T Cell Therapy Raw Material
Table 111. Key Manufacturers of CAR-T Cell Therapy Raw Materials
Table 112. CAR-T Cell Therapy Typical Distributors
Table 113. CAR-T Cell Therapy Typical Customers
LIST OF FIGURES
Figure 1. CAR-T Cell Therapy Picture
Figure 2. Global CAR-T Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global CAR-T Cell Therapy Consumption Value Market Share by Type in 2022
Figure 4. CD19 Examples
Figure 5. BCMA Examples
Figure 6. CD19/CD22 Examples
Figure 7. Other Examples
Figure 8. Global CAR-T Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global CAR-T Cell Therapy Consumption Value Market Share by Application in 2022
Figure 10. Non-hodgkin Lymphoma Examples
Figure 11. Multiple Myeloma Examples
Figure 12. Acute Lymphoblastic Leukemia Examples
Figure 13. Other Examples
Figure 14. Global CAR-T Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global CAR-T Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global CAR-T Cell Therapy Sales Quantity (2018-2029) & (K Units)
Figure 17. Global CAR-T Cell Therapy Average Price (2018-2029) & (US$/Unit)
Figure 18. Global CAR-T Cell Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global CAR-T Cell Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of CAR-T Cell Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 CAR-T Cell Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 CAR-T Cell Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global CAR-T Cell Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global CAR-T Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 25. North America CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 28. South America CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 30. Global CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global CAR-T Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 32. Global CAR-T Cell Therapy Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global CAR-T Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 35. Global CAR-T Cell Therapy Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America CAR-T Cell Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America CAR-T Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 40. United States CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe CAR-T Cell Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe CAR-T Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific CAR-T Cell Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific CAR-T Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 56. China CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America CAR-T Cell Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America CAR-T Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa CAR-T Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. CAR-T Cell Therapy Market Drivers
Figure 77. CAR-T Cell Therapy Market Restraints
Figure 78. CAR-T Cell Therapy Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of CAR-T Cell Therapy in 2022
Figure 81. Manufacturing Process Analysis of CAR-T Cell Therapy
Figure 82. CAR-T Cell Therapy Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. CAR-T Cell Therapy Picture
Figure 2. Global CAR-T Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global CAR-T Cell Therapy Consumption Value Market Share by Type in 2022
Figure 4. CD19 Examples
Figure 5. BCMA Examples
Figure 6. CD19/CD22 Examples
Figure 7. Other Examples
Figure 8. Global CAR-T Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global CAR-T Cell Therapy Consumption Value Market Share by Application in 2022
Figure 10. Non-hodgkin Lymphoma Examples
Figure 11. Multiple Myeloma Examples
Figure 12. Acute Lymphoblastic Leukemia Examples
Figure 13. Other Examples
Figure 14. Global CAR-T Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global CAR-T Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global CAR-T Cell Therapy Sales Quantity (2018-2029) & (K Units)
Figure 17. Global CAR-T Cell Therapy Average Price (2018-2029) & (US$/Unit)
Figure 18. Global CAR-T Cell Therapy Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global CAR-T Cell Therapy Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of CAR-T Cell Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 CAR-T Cell Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 CAR-T Cell Therapy Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global CAR-T Cell Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global CAR-T Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 25. North America CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 28. South America CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa CAR-T Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 30. Global CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global CAR-T Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 32. Global CAR-T Cell Therapy Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global CAR-T Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 35. Global CAR-T Cell Therapy Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America CAR-T Cell Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America CAR-T Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 40. United States CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe CAR-T Cell Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe CAR-T Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific CAR-T Cell Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific CAR-T Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 56. China CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America CAR-T Cell Therapy Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America CAR-T Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa CAR-T Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa CAR-T Cell Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. CAR-T Cell Therapy Market Drivers
Figure 77. CAR-T Cell Therapy Market Restraints
Figure 78. CAR-T Cell Therapy Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of CAR-T Cell Therapy in 2022
Figure 81. Manufacturing Process Analysis of CAR-T Cell Therapy
Figure 82. CAR-T Cell Therapy Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
